Aminopyrazoles as janus kinase inhibitors
US10766883B2 · kind B2 · utility
2Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2017 |
| Grant date | Sep 8, 2020 |
| Priority date | — |
| Expiry date | Dec 7, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The instant invention provides compounds which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.